Trial intelligence / Profile preview

Fluticasone propionate for pediatric snoring due to adenoidal hypertrophy

ChiCTR-OPC-17013596Phase 4Completed

Sponsor
Zhejiang Xiaoshan Hospital
Start
Jan 2013
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of fluticasone propionate in adenoidal hypertrophy (2 arms), sponsored by Zhejiang Xiaoshan Hospital. Primary endpoints: AN ratio and symptom score. Started Jan 2013; status: completed.

02

Drugs

fluticasone propionate
03

Conditions

adenoidal hypertrophy

Beyond the preview

Go deeper on ChiCTR-OPC-17013596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPC-17013596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call